Clinical trial
An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase Under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared With Sensor-augmented Pump Therapy, in Young Children With Type 1 Diabetes.
NCT03671915 is registered in ClinicalTrials.gov with Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase Under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared With Sensor-augmented Pump Therapy, in Young Children With Type 1 Diabetes.
- Lead sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 6, 2019
- Completion date
- December 23, 2019
- Enrollment
- 21 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
closed loop, diabetes mellitus, type 1, young children (6 to 12 years old )